• 54,643+ CME Conference Registrations Sold
  • 163,929+ Medical Conferences
  • 284 Specialties
  • 11,702 Organizers
  • 159,405 Speakers
  • 159 Countries
  • 4,842 Cities
Duration: CME/CE Points: Author(s):
CME : 1

The Role of Radiation Therapy In Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma is organized by American Society for Radiation Oncology (ASTRO) and will be held from Jan 31, 2018 - Jan 30, 2020.

The target audience for this medical event is radiation oncologists and radiation oncology residents. This CME Conference has been approved for a maximum of 1.00 AMA PRA Category 1 Credit.

Provides practitioners with clear guidelines for managing relapsed lymphomas and clear information about new targeted agents now in regular use.

Learning Objectives :
Upon completion of this activity, participants should be able to:
• Define the appropriate use of radiation in the management of refractory lymphoma.

Additional details will be posted as soon as they are available.

Intended Audience

Radiation Oncology, Haematology


Activity Fee : USD $30.00

Onsite to Virtual Conference

Market your online event to Million plus Healthcare professionals.